Cardiovascular Risk Factors and the Long-term Incidence of Age-Related Macular Degeneration. The Blue Mountains Eye Study

Ophthalmology

Volumn 114, Issue 6, 2007, Pages 1143-1150

  Tan, Jennifer S L ^a   Mitchell, Paul ^a   Smith, Wayne ^b   Wang, Jie Jin ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PHYSICAL EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SMOKING HABIT; STEREOSCOPIC VISION; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; NEW SOUTH WALES; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVORS;

EID: 34249680358     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.09.033     Document Type: Article

References (46)

1. Snow K.K., and Seddon J.M. Do age-related macular degeneration and cardiovascular disease share common antecedents?. Ophthalmic Epidemiol 6 (1999) 125-143
2. Mitchell P., Wang J.J., Smith W., and Leeder S.R. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 120 (2002) 1357-1363
3. Tomany S.C., Wang J.J., van Leeuwen R., et al. Risk factors for incident age-related macular degeneration. Pooled findings from 3 continents. Ophthalmology 111 (2004) 1280-1287
4. Klein R., Klein B.E., Tomany S.C., and Moss S.E. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol 156 (2002) 589-598
5. Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19. Ophthalmology 112 (2005) 533-539
6. Hyman L., Schachat A.P., He Q., et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol 118 (2000) 351-358
7. Klein R., Klein B.E., Tomany S.C., Cruickshanks K.J., and The Beaver Dam Eye Study. The association of cardiovascular disease with the long-term incidence of age-related maculopathy. Ophthalmology 110 (2003) 1273-1280
8. Thornton J., Edwards R., Mitchell P., et al. Smoking and age-related macular degeneration: a review of association. Eye 19 (2005) 935-944
9. Smith W., Assink J., Klein R., et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108 (2001) 697-704
10. Klein R., Klein B.E., Marino E.K., et al. Early age-related maculopathy in the cardiovascular health study. Ophthalmology 110 (2003) 25-33
11. Klein R., Clegg L., Cooper L.S., et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 117 (1999) 1203-1210
12. Klein R., Peto T., Bird A., and VanNewkirk M.R. The epidemiology of age-related macular degeneration. Am J Ophthalmol 137 (2004) 486-495
13. Smith W., Mitchell P., Leeder S.R., and Wang J.J. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116 (1998) 583-587
14. Mitchell P., Smith W., Attebo K., and Wang J.J. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology 102 (1995) 1450-1460
15. Klein R., Davis M.D., Magli Y.L., et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology 98 (1991) 1128-1134
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
17. Bird A.C., Bressler N.M., Bressler S.B., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39 (1995) 367-374
18. Wallach J. Interpretation of Diagnostic Tests. 7th ed. (2000), Lippincott Williams & Wilkins, Philadelphia 35-88
19. Klein R., Klein B.E., and Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 100 (1993) 406-414
20. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study report number 3. Ophthalmology 107 (2000) 2224-2232
21. Vingerling J.R., Dielemans I., Bots M.L., et al. Age-related macular degeneration is associated with atherosclerosis: the Rotterdam Study. Am J Epidemiol 142 (1995) 404-409
22. Delcourt C., Michel F., Colvez A., et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 8 (2001) 237-249
23. van Leeuwen R., Ikram M.K., Vingerling J.R., et al. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 44 (2003) 3771-3777
24. Wong T.Y., Klein R., Sun C., et al. Age-related macular degeneration and risk for stroke. Ann Intern Med 145 (2006) 98-106
25. Kinosian B., Glick H., and Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 121 (1994) 641-647
26. van Leeuwen R., Klaver C.C., Vingerling J.R., et al. Cholesterol and age-related macular degeneration: is there a link?. Am J Ophthalmol 137 (2004) 750-752
27. Fazio S., and Linton M.F. Apolipoprotein AI as therapy for atherosclerosis: does the future of preventive cardiology include weekly injections of the HDL protein?. Mol Interv 3 (2003) 436-440
28. Durrington P.N. Biological variation in serum lipid concentrations. Scand J Clin Lab Invest Suppl 198 (1990) 86-91
29. Linn S., Carroll M., Johnson C., et al. High-density lipoprotein cholesterol and alcohol consumption in US white and black adults: data from NHANES II. Am J Public Health 83 (1993) 811-816
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
31. Mitchell P., and Wang J.J. Diabetes, fasting blood glucose and age-related maculopathy: the Blue Mountains Eye Study. Aust N Z J Ophthalmol 27 (1999) 197-199
32. Klein R., Klein B.E., and Moss S.E. Diabetes, hyperglycemia, and age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 99 (1992) 1527-1534
33. Smith W., and Mitchell P. Alcohol intake and age-related maculopathy. Am J Ophthalmol 122 (1996) 743-745
34. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110 (1992) 1701-1708
35. Dasch B., Fuhs A., Behrens T., et al. Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study. Arch Ophthalmol 123 (2005) 1501-1506
36. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294 (2005) 1799-1809
37. Bok D. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc Natl Acad Sci U S A 102 (2005) 7053-7054
38. Mares-Perlman J.A., Brady W.E., Klein R., et al. Dietary fat and age-related maculopathy. Arch Ophthalmol 113 (1995) 743-748
39. Cho E., Hung S., Willett W.C., et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 73 (2001) 209-218
40. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 130 (2000) 658-663
41. Haimovici R., Gantz D.L., Rumelt S., et al. The lipid composition of drusen, Bruch's membrane, and sclera by hot stage polarizing light microscopy. Invest Ophthalmol Vis Sci 42 (2001) 1592-1599
42. Curcio C.A., Millican C.L., Bailey T., and Kruth H.S. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 42 (2001) 265-274
43. Beatty S., Koh H., Phil M., et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45 (2000) 115-134
44. Duncan J.L. Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration. Br J Ophthalmol 89 (2005) 1549-1551
45. Espinosa-Heidmann D.G., Sall J., Hernandez E.P., and Cousins S.W. Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E. Invest Ophthalmol Vis Sci 45 (2004) 260-266
46. Malek G., Johnson L.V., Mace B.E., et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci U S A 102 (2005) 11900-11905